insights_auto
Outlook: 40.0% bullish·13.3% bearish
Go to analysischevron_right
COLL:NASDAQ
Collegium Pharmaceutical Inc
$24.32
arrow_downward
-0.61%(-0.15) 1D
Nov 11, 10:01:31 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 6 analysts giving stock ratings to COLL in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for COLL in the last 3 months.
Highest
Current $24.32
$60.00 (+146.71%)
Average
$46.67 (+91.90%)
Lowest
$28.00 (+15.13%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Alexander Xenakis Truist Financial | Buy | Reiterated | $49.00 | +101.5% | 11/06/2026 |
David Amsellem Piper Sandler | Hold | Reiterated | $28.00 | +15.1% | 11/06/2026 |
Brandon Folkes H.C. Wainwright | Buy | Reiterated | $60.00 | +146.7% | 11/06/2026 |
Jenna Davidner Barclays | Buy | Maintained | $48.00 | +97.4% | 10/15/2026 |
Les Sulewski Oppenheimer | Buy | Reiterated | $50.00 | +105.6% | 10/09/2026 |
Unknown Analyst Oppenheimer | Buy | Initiated | $50.00 | +105.6% | 09/23/2026 |
Daniel Clark Leerink Partners | Buy | Initiated | $45.00 | +85% | 09/09/2026 |
Srikripa Devarakonda Truist Financial | Buy | Maintained | $49.00 | +101.5% | 09/09/2026 |
Serge Belanger Needham | Buy | Maintained | $46.00 | +89.1% | 08/06/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $51.00 | +109.7% | 03/20/2026 |